2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow MTZ: new trials by email Literature Review of MTZ trials Research Report on MTZ
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. ATM-AVI, MTZ, MER - Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia | Phase 3 | Completed | Pfizer | 422 | 2018-04-05 | 2024-12-10 |
| Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia Arsenic trioxide, Idarubicin, Cytarabine - Acute Promyelocytic Leukemia | Phase 3 | Completed | Technische Universität Dresden | 133 | 2016-06-01 | 2026-05-29 |
Leukemia, Promyelocytic, Acute (1) · Pneumonia, Ventilator-Associated (1)
Pfizer (1) · Technische Universität Dresden (1)
Italy (2) · Spain (2) · Argentina (1) · Bulgaria (1) · China (1) · Croatia (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · India (1) · Israel (1) · Malaysia (1) · Mexico (1) · Netherlands (1)
Uwe Platzbecker, Prof. Dr. (1)
PMID 38252170, PMID 39389071, PMID 40530972, PMID 40825164, PMID 41269522
2017 (1)